What are the main functions and specific effects of Platinib?

Pralsetinib is a targeted anti-cancer drug targeting RET gene fusion mutations. Its core mechanism of action is to selectively inhibit RET tyrosine kinase activity, thereby blocking signaling pathways related to tumor cell growth, proliferation and metastasis. In RET fusion-positive non-small cell lung cancer (NSCLC) and certain types of thyroid cancer, abnormal activation of the RET gene drives tumor occurrence and progression. Therefore, by precisely targeting the RET signaling axis, platinib can significantly inhibit tumor development and improve clinical symptoms.

Its main therapeutic efficacy is reflected in several aspects: First, platinib has shown a significant objective response rate (ORR) in RET fusion-positive advanced NSCLC. Many patients have seen their tumors shrink or control their progression after receiving treatment, thereby improving common lung cancers such as dyspnea and cough. Symptoms; secondly, platinib has good central nervous system penetration ability and has a certain therapeutic effect on patients with brain metastases, which is difficult to achieve in traditional chemotherapy regimens; thirdly, compared with traditional chemotherapy, platinib has relatively mild side effects, and most patients can take it for a long time, which improves the quality of life and compliance.

In addition, platinib is also used to treat RET-mutant medullary thyroid cancer and certain childhood tumors, but its most mature application scenario is still RET fusion-positive NSCLC. Its development and application represent the new trend of "accurate gene matching" in the field of molecular targeted therapy, promoting the development of lung cancer treatment in a more efficient and less toxic direction.

It should be noted that although platinib is a targeted therapy drug, it may still cause adverse reactions such as hypertension, elevated liver enzymes, and constipation. Therefore, patients need to regularly monitor liver function and blood pressure during medication. During treatment, doctors may also make dose adjustments based on patient tolerance to achieve a balance between maximum efficacy and minimum side effects.

Reference: https://gavreto.com/